2012 Highlights of ASH? in Asia
- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÀÛ¼ºÀÏ
- 2012-01-02
- Á¶È¸
- 4993
2012 Highlights of ASH? in Asia
March 3-4, 2012
Singapore
Download the HOA Asia brochure
Plan to Attend
At Highlights of ASH? you will:
- Hear leading experts in hematology discuss evolving therapies, the latest treatment options, and their clinical applications from the 53rd ASH Annual Meeting – the premier hematology meeting in the world
- Have opportunities to ask the experts questions about your challenging patient cases during panel discussions and in small-group settings
- Network with the faculty and your colleagues
Program Topics
- Myelodysplastic Syndromes
- Acute Leukemias
- Myeloproliferative Diseases including Chronic Myeloid Leukemia
- Hematopoietic Stem Cell Transplantation
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Disorders of Hemostasis
- Thrombosis and Anticoagulation
- Thalassemia
- Novel Treatments for Relapsed/Refractory Chronic Immune Thrombocytopenia
- Bone Marrow Failure
- Plasma Cell Disorders (Myeloma)
- How to Prepare a Manuscript for Submission to Blood
- How to Prepare an Abstract for Submission to the American Society of Hematology\'s Annual Meeting
Partner Societies
This meeting is being presented by the American Society of Hematology (ASH) and the Cancer Science Institute of Singapore, National University of Singapore (CSI/NUS) in partnership with:- Hematology Society of Taiwan
- Japanese Society of Hematology (JSH)
- Korean Society of Hematology (KSH)
- Thai Society of Hematology (TSH)
- Hematology Society of Australia and New Zealand (HSANZ)
- Chinese Society of Hematology (CSH)
- National University Cancer Institute of Singapore (NCIS)
- Singapore Society of Hematology
- Indian Society of Hematology and Blood Transfusion (ISHBT)
Program Co-Chairs
- Charles T. Quinn, MD, MS, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH
- Mikkael A. Sekeres, MD, MS, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
- Wee Joo Chng, MD, Cancer Science Institute of Singapore, National University of Singapore
- Daniel Tenen, MD, Director, Cancer Science Institute of Singapore Distinguished Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore